Recent Updates
Recently added Catalysts
RADX Positive Sentiment Score: 60/100

Entitlement Offer closing date extended to 1 December 2023

Tuesday, November 21, 2023 1 min read
Key Takeaway: Radiopharm Theranostics has announced an extension of the closing date for its entitlement offer to December 1, 2023. This decision aims to provide more investors the opportunity to participate in the funding initiative. The extension reflects the company's commitment to enhancing investor engagement and securing necessary capital for future projects.

Market Sentiment Analysis

POSITIVE FACTORS

  • Entitlement offer provides additional funding opportunities.
  • Extension allows more investors to participate.
  • Positive outlook for Radiopharm Theranostics' future projects.

Full Press Release Details

• Announcements
• November 21, 2023
Loading Viewer…

More Announcements & Updates

• Announcements
• August 8, 2023
• Announcements
• September 28, 2023
• Announcements
• September 28, 2023
• Announcements
• October 20, 2022

Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)

Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

CLINICAL UPDATE AND CAPITAL RAISING OCTOBER 20th, 2025

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)

Dr. Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

• RAD Presentation June 2026
• Zacks Small-Cap Research 2026
• RAD Presentation March 2026
• Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)
• Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
• Zacks Small-Cap Research

Frequently Asked Questions

What is the new closing date for the entitlement offer?

The new closing date for the entitlement offer is December 1, 2023.

Why was the entitlement offer closing date extended?

The closing date was extended to allow more investors to participate in the funding initiative.

What does the entitlement offer aim to achieve?

The entitlement offer aims to secure necessary capital for Radiopharm Theranostics' future projects.

Tags: RADX Viatris Investor Conferences Healthcare Radiopharm Theranostics entitlement offer funding clinical study
Last updated: Nov 21, 2023